Analyses of cellular multimerin 1 receptors: in vitro evidence of binding mediated by αΙΙbβ3 and αvβ3

Summary

Multimerin 1 (MMRN1) is a large, soluble, polymeric, factor V binding protein and member of the EMILIN protein family.In vivo, MMRN1 is found in platelets, megakaryocytes, endothelium and extracellular matrix fibers, but not in plasma. To address the mechanism of MMRN1 binding to activated platelets and endothelial cells, we investigated the identity of the major MMRN1 receptors on these cells using wild-type and RGE-forms of recombinant MMRN1. Ligand capture, cell adhesion, ELISA and flow cytometry analyses of platelet-MMRN1 binding, indicated that MMRN1 binds to integrins αIIbβ3 and αvβ3. Endothelial cell binding to MMRN1 was predominantly mediated by αvβ3 and did not require the MMRN1 RGD site or cellular activation. Like many other αvβ3 ligands, MMRN1 had the ability to support adhesion of additional cell types, including stimulated neutrophils. Expression studies, using a cell line capable of endothelial-like MMRN1 processing, indicated that MMRN1 adhesion to cellular receptors enhanced its extracellular matrix fiber assembly. These studies implicate integrin-mediated binding in MMRN1 attachment to cells and indicate that MMRN1 is a ligand for αIIbβ3 and αvβ3.

Keywords

Multimerin 1 - cell adhesion - integrin - platelet - endothelial cell

• References

• 1 Hayward CP. Multimerin: a bench-to-bedside chronology of a unique platelet and endothelial cell protein– from discovery to function to abnormalities in disease. Clin Invest Med 1997; 20: 176-87.
• 2 Colombatti A, Doliana R, Bot S. et al. The EMILIN protein family. Matrix Biol 2000; 19: 289-301.
• 3 Hayward CP, Smith JW, Horsewood P. et al. p-155, a multimeric platelet protein that is expressed on activated platelets. J Biol Chem 1991; 266: 7114-20.
• 4 Hayward CP, Bainton DF, Smith JW. et al. Multimerin is found in the alpha-granules of resting platelets and is synthesized by a megakaryocytic cell line. J Clin Invest 1993; 91: 2630-9.
• 5 Hayward CP, Hassell JA, Denomme GA. et al. The cDNA sequence of human endothelial cell multimerin. A unique protein with RGDS, coiled-coil, and epidermal growth factor-like domains and a carboxyl terminus similar to the globular domain of complement C1q and collagens type VIII and X. J Biol Chem 1995; 270: 18246-51.
• 6 Christian S, Ahorn H, Novatchkova M. et al. Molecular cloning and characterization of EndoGlyx-1, an EMILIN-like multisubunit glycoprotein of vascular endothelium. J Biol Chem 2001; 276: 48588-95.
• 7 Hayward CP, Warkentin TE, Horsewood P. et al. Multimerin: a series of large disulfide-linked multimeric proteins within platelets. Blood 1991; 77: 2556-60.
• 8 Veljkovic DK, Cramer EM, Alimardani G. et al. Studies of alpha-granule proteins in cultured human megakaryocytes. Thromb Haemost 2003; 90: 844-52.
• 9 Hayward CP, Cramer EM, Song Z. et al. Studies of multimerin in human endothelial cells. Blood 1998; 91: 1304-17.
• 10 Hayward CP, Furmaniak-Kazmierczak E, Cieutat AM. et al. Factor V is complexed with multimerin in resting platelet lysates and colocalizes with multimerin in platelet alpha-granules. J Biol Chem 1995; 270: 19217-24.
• 11 Hayward CP, Weiss HJ, Lages B. et al. The storage defects in grey platelet syndrome and alphadelta-storage pool deficiency affect alpha-granule factor V and multimerin storage without altering their proteolytic processing. Br J Haematol 2001; 113: 871-7.
• 12 Jeimy SB, Woram RA, Fuller N. et al. Identification of the MMRN1 binding region within the C2 domain of human factor V. J Biol Chem 2004; 279: 51466-71.
• 13 Hayward CP, Fuller N, Zheng S. et al. Human platelets contain forms of factor V in disulfide-linkage with multimerin. Thromb Haemost 2004; 92: 1349-57.
• 14 Hayward CP, Song Z, Zheng S. et al. Multimerin processing by cells with and without pathways for regulated protein secretion. Blood 1999; 94: 1337-47.
• 15 Hayward CP, Rivard GE, Kane WH. et al. An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect. Blood 1996; 87: 4967-78.
• 16 Bergendahl V, Anthony LC, Heyduk T. et al. On-column tris(2-carboxyethyl)phosphine reduction and IC5-maleimide labeling during purification of a RpoC fragment on a nickel-nitrilotriacetic acid Column. Anal Biochem 2002; 307: 368-74.
• 17 Chakrabarti S, Patel KD. Regulation of matrix metalloproteinase-9 release from IL-8-stimulated human neutrophils. J Leukoc Biol 2005; 78: 279-88.
• 18 Hughes M, Hayward CP, Warkentin TE. et al. Morphological analysis of microparticle generation in heparin- induced thrombocytopenia. Blood 2000; 96: 188-94.
• 19 Tuszynski GP, Murphy A. Spectrophotometric quantitation of anchorage-dependent cell numbers using the bicinchoninic acid protein assay reagent. Anal Biochem 1990; 184: 189-91.
• 20 Wagner CL, Mascelli MA, Neblock DS. et al. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood 1996; 88: 907-14.
• 21 Lam SC, Plow EF, D’Souza SE. et al. Isolation and characterization of a platelet membrane protein related to the vitronectin receptor. J Biol Chem 1989; 264: 3742-9.
• 22 Tam SH, Sassoli PM, Jordan RE. et al. Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/ IIIa and alpha(v)beta3 integrins. Circulation 1998; 98: 1085-91.
• 23 Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 1996; 12: 697-715.
• 24 Weisel JW, Nagaswami C, Vilaire G. et al. Examination of the platelet membrane glycoprotein IIb-IIIa complex and its interaction with fibrinogen and other ligands by electron microscopy. J Biol Chem 1992; 267: 16637-43.
• 25 Holmback K, Danton MJ, Suh TT. et al. Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin alpha IIb beta 3. Embo J 1996; 15: 5760-71.
• 26 Nurden AT, Nurden P. GPIIb/IIIa antagonists and other anti-integrins. Semin Vasc Med 2003; 3: 123-30.
• 27 Berton G, Lowell CA. Integrin signalling in neutrophils and macrophages. Cell Signal 1999; 11: 621-35.
• 28 Spessotto P, Cervi M, Mucignat MT. et al. beta 1 Integrin- dependent cell adhesion to EMILIN-1 is mediated by the gC1q domain. J Biol Chem 2003; 278: 6160-7.
• 29 Gartner TK, Amrani DL, Derrick JM. et al. Characterization of adhesion of “resting” and stimulated platelets to fibrinogen and its fragments. Thromb Res 1993; 71: 47-60.
• 30 Savage B, Bottini E, Ruggeri ZM. Interaction of integrin αIIbβ3 with multiple fibrinogen domains during platelet adhesion. J Biol Chem 1995; 270: 28812-7.
• 31 Zaidi TN, McIntire LV, Farrell DH. et al. Adhesion of platelets to surface-bound fibrinogen under flow. Blood 1996; 88: 2967-72.
• 32 Byzova TV, Plow EF. Activation of alphaVbeta3 on vascular cells controls recognition of prothrombin. J Cell Biol 1998; 143: 2081-92.
• 33 Rolli M, Fransvea E, Pilch J. et al. Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100: 9482-7.
• 34 Schmugge M, Rand ML, Freedman J. Platelets and von Willebrand factor. Transfus Apheresis Sci 2003; 28: 269-77.
• 35 Sottile J, Hocking DC. Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol Biol Cell 2002; 13: 3546-59.
• 36 Ni H, Denis CV, Subbarao S. et al. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 2000; 106: 385-92.
• 37 Bonnefoy A, Hantgan R, Legrand C. et al. A model of platelet aggregation involving multiple interactions of thrombospondin-1, fibrinogen, and GPIIbIIIa receptor. J Biol Chem 2001; 276: 5605-12.
• 38 Hu DD, White CA, Panzer-Knodle S. et al. A new model of dual interacting ligand binding sites on integrin alphaIIbbeta3. J Biol Chem 1999; 274: 4633-9.
• 39 Mekrache M, Kieffer N, Baruch D. Activation of recombinant alphaIIbbeta3 expressed in Chinese hamster ovary cells exposes different binding sites for fibrinogen or von Willebrand factor: evidence using monoclonal antibodies to alphaIIbbeta3. Br J Haematol 2002; 116: 636-44.
• 40 Hantgan RR, Simpson-Haidaris PJ, Francis CW. et al. Fibrinogen structure and physiology. Hemostasis and thrombosis.. Fourth ed: Lippincott Williams & Wilkins;; 2001: 202-232.
• 41 Pietu G, Cherel G, Marguerie G. et al. Inhibition of von Willebrand factor-platelet interaction by fibrinogen. Nature 1984; 308: 648-9.
• 42 Braghetta P, Ferrari A, DeGemmis P. et al. Overlapping, complementary and site-specific expression pattern of genes of the EMILIN/Multimerin family. Matrix Biol 2004; 22: 549-56.
• 43 Specht CG, Schoepfer R. Deletion of multimerin-1 in alpha-synuclein-deficient mice. Genomics 2004; 83: 1176-8.
• 44 Specht CG, Schoepfer R. Deletion of the alphasynuclein locus in a subpopulation of C57BL/6J inbred mice. BMC Neurosci 2001; 2: 11.